Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of a topically active imiquimod formulation.

J L Chollet1, M J Jozwiakowski, K R Phares

  • 13M Pharmaceuticals, St. Paul, Minnesota, USA.

Pharmaceutical Development and Technology
|February 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thiazolidinedione drugs block cardiac KATP channels and may increase propensity for ischaemic ventricular fibrillation in pigs.

Diabetologia·2008
Same author

Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells.

Leukemia·2005
Same author

Imiquimod 5% cream (Aldara).

Expert opinion on investigational drugs·2005
Same author

The journal club in postgraduate medical education: a systematic review.

Medical teacher·2002
Same author

[Automated quality control of diagnostic ultrasound appliances].

Ultraschall in der Medizin (Stuttgart, Germany : 1980)·2002
Same author

Immunomodulation as a treatment strategy for genital herpes: review of the evidence.

International immunopharmacology·2002
Same journal

Enhanced solubility and bioavailability of zanubrutinib nanocrystals: Physicochemical and Pharmacokinetic evaluation.

Pharmaceutical development and technology·2026
Same journal

Intradermal delivery of lidocaine hydrochloride using dissolving microneedles: <i>In vitro</i> dermatokinetic test and <i>in vivo</i> anesthetic activity assessment.

Pharmaceutical development and technology·2026
Same journal

Quality by Design-Guided Development of Silica-Enabled Lipid Hybrid Nanoparticles for Enhanced Olaparib Dissolution.

Pharmaceutical development and technology·2026
Same journal

Surface engineering of nanocarriers with polymer coatings: materials, strategies, functional outcomes, and clinical translation.

Pharmaceutical development and technology·2026
Same journal

Compression equations in pharmaceutical tableting: from classical compaction models to data-driven and mechanistic approaches.

Pharmaceutical development and technology·2026
Same journal

Intranasal mucoadhesive biomaterials for nose-to-brain neuroactive delivery: platform design and model-informed translation for time-bounded CNS exposure.

Pharmaceutical development and technology·2026
See all related articles

This study developed a stable topical imiquimod cream for treating genital warts. The formulation effectively induced local immune responses, showing potential for therapeutic use.

Area of Science:

  • Dermatology
  • Pharmaceutical Sciences
  • Immunology

Background:

  • Imiquimod is an immune response modifier used for treating external genital and perianal warts.
  • Developing a stable and effective topical formulation is crucial for its therapeutic application.

Purpose of the Study:

  • To develop a topical oil-in-water cream formulation of imiquimod (5% concentration).
  • To ensure the formulation induces local cytokine production for wart treatment.

Main Methods:

  • Determined imiquimod's pKa (7.3) and solubility profile.
  • Selected isostearic acid (ISA) as the preferred solvent for imiquimod.
  • Utilized polysorbate 60, sorbitan monostearate, and xanthan gum for cream stability.
  • Incorporated parabens and benzyl alcohol as a preservative system.

Related Experiment Videos

  • Developed an in vitro release method and tested topical application in mice.

    • Main Results:

    • Identified a relationship between ISA fatty acid composition and imiquimod solubility.
    • Achieved a physically stable oil-in-water cream formulation.
    • Demonstrated imiquimod release from the formulation in vitro.
    • Confirmed induction of local cytokine activity in mice following topical application.

    Conclusions:

    • A stable and effective topical imiquimod cream formulation was successfully developed.
    • The formulation has the potential to induce local cytokine production for treating external genital and perianal warts.